Javascript must be enabled to continue!
Abstract 17614: Genome-Wide Association Study of Aspirin Responsiveness in African Americans
View through CrossRef
While familial studies have established that inter-individual variability in platelet response to aspirin (ASA) is partly due to genetic variation, a genome-wide association study (GWAS) has not been reported in African Americans. Fasting blood samples were obtained from healthy African Americans (N=868) with family history of premature coronary artery disease. Optical aggregation was measured in platelet-rich plasma (PRP) after samples were stimulated with collagen (1, 2, 5 µg/mL), ADP (2, 10 µmol/L), or epinephrine (2, 10 µmol/L) before and after 14-days of ASA therapy. A cohort of European ancestry (N=1236) provided replication. In each cohort, age- and sex-adjusted linear mixed effects models adjusting for family structure were used to test for association between each SNP and each phenotype under an additive model. We analyzed data with adjustment for pre-ASA platelet studies to examine the pure effect of ASA and without adjustment which is likely to be closer to the clinically observed effect. We sought region-based replication with adjustment for the number of LD blocks in HapMap CEU population. We observed SNPs in 3 regions (2 intronic and 1 intergenic) that crossed GWAS threshold of significance (p<5 x 10
-8
). A SNP in the
PEAR1
gene, rs12041331, was significantly associated with most doses of the three agonists and this association remained significant after adjusting for pre-ASA platelet studies (Table). In the replication cohort, rs12041331 was also nominally significant. SNPs close to the other two GWAS-significant SNPs were nominally significant in the replication cohort after adjusting for the LD structure. In this first GWAS of platelet response to ASA therapy in African Americans, we show a relationship between post-ASA platelet reactivity and 3 regions, and replicate these findings in an independent sample. Both
PEAR1
and
CRB1
are expressed in platelets and are good candidates for follow-up studies examining ASA responsiveness.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 17614: Genome-Wide Association Study of Aspirin Responsiveness in African Americans
Description:
While familial studies have established that inter-individual variability in platelet response to aspirin (ASA) is partly due to genetic variation, a genome-wide association study (GWAS) has not been reported in African Americans.
Fasting blood samples were obtained from healthy African Americans (N=868) with family history of premature coronary artery disease.
Optical aggregation was measured in platelet-rich plasma (PRP) after samples were stimulated with collagen (1, 2, 5 µg/mL), ADP (2, 10 µmol/L), or epinephrine (2, 10 µmol/L) before and after 14-days of ASA therapy.
A cohort of European ancestry (N=1236) provided replication.
In each cohort, age- and sex-adjusted linear mixed effects models adjusting for family structure were used to test for association between each SNP and each phenotype under an additive model.
We analyzed data with adjustment for pre-ASA platelet studies to examine the pure effect of ASA and without adjustment which is likely to be closer to the clinically observed effect.
We sought region-based replication with adjustment for the number of LD blocks in HapMap CEU population.
We observed SNPs in 3 regions (2 intronic and 1 intergenic) that crossed GWAS threshold of significance (p<5 x 10
-8
).
A SNP in the
PEAR1
gene, rs12041331, was significantly associated with most doses of the three agonists and this association remained significant after adjusting for pre-ASA platelet studies (Table).
In the replication cohort, rs12041331 was also nominally significant.
SNPs close to the other two GWAS-significant SNPs were nominally significant in the replication cohort after adjusting for the LD structure.
In this first GWAS of platelet response to ASA therapy in African Americans, we show a relationship between post-ASA platelet reactivity and 3 regions, and replicate these findings in an independent sample.
Both
PEAR1
and
CRB1
are expressed in platelets and are good candidates for follow-up studies examining ASA responsiveness.
Related Results
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Objective: To evaluate and provide management strategies for patients with aspirin or nonselective nonsteroidal antiinflammatory drug (NSAID) sensitivity. Data Sources: Literature ...
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Aspirin, commonly used for prevention of cardiovascular and cerebrovascular diseases, has been found to possess protective effects against cancer development in the Western populat...
African Americans in Europe
African Americans in Europe
African Americans have an extensive history and continuing presence in Europe. This reflects the artistic, cultural, and intellectual exchanges between the peoples of Europe and th...
Aspirin usage in patients with essential hypertension
Aspirin usage in patients with essential hypertension
Objective
To investigate the use of aspirin in patients with essential hypertension complicated with different risk factors and clinical conditions.
...
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract
Epidemiological studies have demonstrated a significant correlation between regular aspirin use and reduced colon cancer incidence and mortality. Although a...
Exaggerated insulin secretion in Pima Indians and African‐Americans but higher insulin resistance in Pima Indians compared to African‐Americans and Caucasians
Exaggerated insulin secretion in Pima Indians and African‐Americans but higher insulin resistance in Pima Indians compared to African‐Americans and Caucasians
AbstractAims African‐Americans have a higher prevalence of Type 2 diabetes than Caucasians, but a lower prevalence than Pima Indians. Studies suggest that both African‐Americans a...
Aspirin promotes ferroptosis by attenuating Nrf2 in triple-negative breast cancer
Aspirin promotes ferroptosis by attenuating Nrf2 in triple-negative breast cancer
Abstract
Purpose
Recent research has found that patients who receive aspirin might have a reduced risk of breast cancer. However, how aspirin influences cancer remains con...
Abstract 3501: Aspirin modulates oncogene expression in hct 116 colon cancer cells
Abstract 3501: Aspirin modulates oncogene expression in hct 116 colon cancer cells
Abstract
Aspirin is a 100 year old Non-steroidal anti-inflammatory drug (NSAID). Beside its use a cardio-protective agent, it is also used for treatment of headache,...

